Spark, a lightweight real-time coding model powered by Cerebras hardware and optimized for ultra-low latency performance.

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...

Veeva Systems shares were 7% higher, at $235.89, after the company said its board of directors approved a share-repurchase program with authorization to buy up to $2 billion of its shares. Under the ...

The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...

The Details: Veeva reported quarterly earnings of $2.04 per share, which beat the analyst estimate of $1.95. Quarterly revenue of $811.2 million beat the Street estimate of $792.82 million.

The latest announcement is out from Veeva Systems ( (VEEV)). On November 17, 2025, Veeva Systems Inc. announced that Kristine Diamond, the Chief Accounting Officer, will resign from her position ...

Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...

Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen to find ways to improve clinical trial processes. Amgen will take ...

Veeva previously faced restrictions on integrating IQVIA’s industry-leading data into its commercial products, such as Veeva Network and Nitro, which limited competitiveness. The company has now ...